SMARCA4 and SMARCA2 are mutually exclusive catalytic subunits of the SWI/SNF complex, and the inhibition of SMARCA2 activity appears to be synthetic lethal in cancer cells carrying SMARCA4-inactivating mutations, an effect that could be explained by paralogue insufficiency12,13. This evidence concerns the gene SMARCA4 and cancer.